NYSE · Healthcare
Mirion Technologies, Inc. (MIR)
As-reported financials and recent SEC filings for Mirion Technologies, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$925.4M
Net income
$28.8M
Net margin
3.1%
Diluted EPS
$0.11
ROE
1.5%
P/E (TTM)
184.5×
Market cap
$4.51B
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $925.4M | $860.8M | $800.9M | $717.8M | — |
| Gross profit | $438.6M | $399.7M | $356.4M | $310.1M | — |
| Operating income | $51.5M | $24.8M | $-21.9M | $-297.8M | — |
| Net income | $28.8M | $-36.1M | $-96.9M | $-276.9M | $-158.4M |
| Diluted EPS | $0.11 | $-0.18 | $-0.49 | $-1.53 | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-05-29
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →Go deeper on MIR
Search Mirion Technologies, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.